Sign in

CIK 0001850902

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

Alpha Teknova, Inc.

Sign in to watch
Ticker
TKNO
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
943368109
Phone
+1 831-637-1100
Business address
2451 BERT DRIVE, HOLLISTER, CA, 95023
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-03-06 Lowell Matthew Chief Financial Officer Purchase +40,000 $2.19 $88K 168,376
2026-02-15 Lowell Matthew Chief Financial Officer Grant or award · Non-Qualified Stock Option (right to buy) +171,000 171,000
2025-02-14 Lowell Matthew Chief Financial Officer Grant or award · Non-Qualified Stock Option (right to buy) +169,857 169,857
2024-07-12 Lowell Matthew Chief Financial Officer Purchase +40,322 $1.24 $50K 128,376
2023-09-19 Lowell Matthew Chief Financial Officer Purchase +54,054 $1.85 $100K 88,054
2023-02-27 Lowell Matthew Chief Financial Officer Grant or award +14,000 34,000
2023-02-27 Lowell Matthew Chief Financial Officer Grant or award · Non-Qualified Stock Option (right to buy) +28,000 28,000
2022-11-15 Lowell Matthew Chief Financial Officer Grant or award · Non-Qualified Stock Option (right to buy) +33,093 33,093
2022-09-01 Lowell Matthew Chief Financial Officer Purchase +10,000 $4.61 $46K 20,000
2022-05-20 Lowell Matthew Chief Financial Officer Purchase +10,000 $9.45 $94K 10,000
2022-02-15 Lowell Matthew Chief Financial Officer Grant or award · Non-Qualified Stock Option (right to buy) +60,000 60,000
2021-06-24 Lowell Matthew Chief Financial Officer Grant or award · Stock Option (Right to buy) +6,186 6,186

Page 1 of 1 · 12 trades